Table 3.
Lung n = 45 |
Urinary tract n = 33 |
Other sites n = 19 |
p value | |
---|---|---|---|---|
IRP+ | 17(37.8%) | 7(22.5%) | 5(26.3%) | 0.36 |
CD4/CD8 < 1 | 6(13.9%) | 4(12.1%) | 0 (0%) | 0.26 |
CD8 T-cells > 600 | 9(20.9%) | 4(12.1%) | 4(21.5%) | 0.60 |
CD28-CD8+ T-cells > 300 | 17(37.7%) | 9(30%) | 5(27.7%) | 0.73 |
Positive CMV serology | 39 (86.6%) | 22 (68.7%) | 15 (78.9%) | 0.16 |
Patients with infection at several sites were classified based on the site involved initially.